1. Inicio
  2. Publicaciones
  3. Comparison of Left Bundle Branch Area Pacing and Biventricular Pacing in Candidates for Resynchronization Therapy

Comparison of Left Bundle Branch Area Pacing and Biventricular Pacing in Candidates for Resynchronization Therapy

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Vijayaraman, P
  • Sharma, PS
  • Ponnusamy, SS
  • Herweg, B
  • Zanon, F
  • Jastrzebski, M
  • Zou, JA
  • Chelu, MG
  • Vernooy, K
  • Whinnett, ZI
  • Nair, GM
  • Molina-Lerma, M
  • Curila, K
  • Zalavadia, D
  • Haseeb, A
  • Dye, C
  • Vipparthy, SC
  • Brunetti, R
  • Moskal, P
  • Ross, A
  • van Stipdonk, A
  • George, J
  • Qadeer, YK
  • Mumtaz, M
  • Kolominsky, J
  • Zahra, SA
  • Golian, M
  • Marcantoni, L
  • Subzposh, FA
  • Ellenbogen, KA

Grupos

Abstract

BACKGROUND Cardiac resynchronization therapy (CRT) with biventricular pacing (BVP) is a well established therapy in patients with reduced left ventricular ejection fraction (LVEF), heart failure, and wide QRS or expected frequent ven-tricular pacing. Left bundle branch area pacing (LBBAP) has recently been shown to be a safe alternative to BVP.OBJECTIVES The aim of this study was to compare the clinical outcomes between BVP and LBBAP among patients undergoing CRT. METHODS This observational study included patients with LVEF #35% who underwent BVP or LBBAP for the first time for Class I or II indications for CRT from January 2018 to June 2022 at 15 international centers. The primary outcome was the composite endpoint of time to death or heart failure hospitalization (HFH). Secondary outcomes included endpoints of death, HFH, and echocardiographic changes.RESULTS A total of 1,778 patients met inclusion criteria: 981 BVP, 797 LBBAP. The mean age was 69 & PLUSMN; 12 years, 32% were female, 48% had coronary artery disease, and mean LVEF was 27% & PLUSMN; 6%. Paced QRS duration in LBBAP was significantly narrower than baseline (128 & PLUSMN; 19 ms vs 161 & PLUSMN; 28 ms; P < 0.001) and significantly narrower compared to BVP (144 & PLUSMN; 23 ms; P < 0.001). Following CRT, LVEF improved from 27% & PLUSMN; 6% to 41% & PLUSMN; 13% (P < 0.001) with LBBAP compared with an increase from 27% & PLUSMN; 7% to 37% & PLUSMN; 12% (P < 0.001) with BVP, with significantly greater change from baseline with LBBAP (13% & PLUSMN; 12% vs 10% & PLUSMN; 12%; P < 0.001). On multivariable regression analysis, the primary outcome was significantly reduced with LBBAP compared with BVP (20.8% vs 28%; HR: 1.495; 95% CI: 1.213-1.842; P < 0.001).CONCLUSIONS LBBAP improved clinical outcomes compared with BVP in patients with CRT indications and may be a reasonable alternative to BVP. (J Am Coll Cardiol 2023;82:228-241) & COPY; 2023 by the American College of Cardiology Foundation.

Datos de la publicación

ISSN/ISSNe:
0735-1097, 1558-3597

JACC-Journal of the American College of Cardiology  ELSEVIER SCIENCE INC

Tipo:
Article
Páginas:
228-241
PubMed:
37220862
Factor de Impacto:
9,756 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 218

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • biventricular pacing; cardiac resynchronization therapy; heart failure hospitalization; left bundle branch area pacing; mortality

Campos de Estudio

Cita

Compartir